Cargando…
An Acute, Placebo-Controlled, Single-Blind, Crossover, Dose-Response, Exploratory Study to Assess the Effects of New Zealand Pine Bark Extract (Enzogenol(®)) on Glycaemic Responses in Healthy Participants
An acute, placebo-controlled, single-blind, crossover, dose-response, exploratory study was designed to investigate the hypoglycaemic effects of New Zealand pine bark extract (Enzogenol(®)). Twenty-five healthy participants categorised into having a monophasic or complex (biphasic or triphasic) gluc...
Autores principales: | Lim, Wen Xin Janice, Chepulis, Lynne, von Hurst, Pamela, Gammon, Cheryl S., Page, Rachel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071219/ https://www.ncbi.nlm.nih.gov/pubmed/32075228 http://dx.doi.org/10.3390/nu12020497 |
Ejemplares similares
-
The Inhibitory Effects of New Zealand Pine Bark (Enzogenol(®)) on α-Amylase, α-Glucosidase, and Dipeptidyl Peptidase-4 (DPP-4) Enzymes
por: Lim, Wen Xin Janice, et al.
Publicado: (2022) -
A Narrative Review of Human Clinical Trials on the Impact of Phenolic-Rich Plant Extracts on Prediabetes and Its Subgroups
por: Lim, Wen Xin Janice, et al.
Publicado: (2021) -
Barriers to Diabetes Self-Management in a Subset of New Zealand Adults with Type 2 Diabetes and Poor Glycaemic Control
por: Chepulis, Lynne, et al.
Publicado: (2021) -
Suboptimal monitoring of glucose levels and poor glycaemic control is associated with increased mortality and length of stay in adult inpatients with diabetes in a tertiary New Zealand hospital
por: Duggan, Dave A, et al.
Publicado: (2023) -
Prevalence of gestational diabetes in the Waikato region of New Zealand
por: Chepulis, Lynne, et al.
Publicado: (2022)